The partnership will expand patients’ access to clinical trials in New Jersey and reduce the need to travel to New York City for cancer care.
According to Robert Korst, MD, director of Valley Health System’s Blumenthal Cancer Center, introducing Mount Sinai’s renowned cancer care brand could attract many more patients to Valley Health System facilities.
The focus of the partnership is the opening of a new clinical genomic unit at Valley Health System, as well as the collaboration for a clinically integrated trial system, according to the report.
“This relationship with Mount Sinai will benefit our community by offering access to an expanded roster of clinical trials, programs and services for patients diagnosed with cancer,” Valley Health CEO Audrey Meyers said in a statement. “We look forward to working with Mount Sinai to bring world-class cancer care to the residents of northern New Jersey.”
More articles on hospital and physician issues:
MACRA comment period closes today
MinuteClinic adds clinics in South Florida Target stores
Are physicians really prescribing more in exchange for free lunches? 4 thoughts
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
